News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,992 Results
Type
Article (38959)
Company Profile (276)
Press Release (643757)
Section
Business (203819)
Career Advice (1985)
Deals (35356)
Drug Delivery (84)
Drug Development (80765)
Employer Resources (168)
FDA (16084)
Job Trends (14796)
News (344457)
Policy (32429)
Tag
Academia (2530)
Alliances (49035)
Alzheimer's disease (1212)
Approvals (16002)
Artificial intelligence (114)
Bankruptcy (352)
Best Places to Work (11458)
Biotechnology (196)
Breast cancer (101)
Cancer (886)
Cardiovascular disease (76)
Career advice (1656)
Cell therapy (193)
Clinical research (63887)
Collaboration (317)
Compensation (158)
COVID-19 (2520)
Cystic fibrosis (78)
Data (829)
Diabetes (128)
Diagnostics (6091)
Earnings (84091)
Employer resources (146)
Events (108757)
Executive appointments (239)
FDA (16514)
Funding (286)
Gene therapy (146)
GLP-1 (554)
Government (4316)
Healthcare (18649)
Infectious disease (2593)
Inflammatory bowel disease (101)
Interviews (308)
IPO (16263)
Job creations (3622)
Job search strategy (1415)
Layoffs (407)
Legal (7847)
Lung cancer (154)
Manufacturing (148)
Medical device (13140)
Medtech (13145)
Mergers & acquisitions (19100)
Metabolic disorders (348)
Neuroscience (1450)
NextGen Class of 2024 (6493)
Non-profit (4462)
Northern California (1177)
Obesity (209)
Opinion (175)
Patents (94)
People (56106)
Phase I (19814)
Phase II (28128)
Phase III (21007)
Pipeline (202)
Postmarket research (2553)
Preclinical (8422)
Radiopharmaceuticals (234)
Rare diseases (178)
Real estate (5888)
Regulatory (21425)
Research institute (2307)
Resumes & cover letters (349)
Southern California (1062)
Startups (3560)
United States (11422)
Vaccines (533)
Weight loss (156)
Date
Last 7 days (773)
Last 30 days (2634)
Last 365 days (35546)
2024 (30096)
2023 (40074)
2022 (51174)
2021 (55712)
2020 (54087)
2019 (46542)
2018 (35019)
2017 (32110)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (186)
Asia (36999)
Australia (6034)
California (2665)
Canada (1163)
China (207)
Colorado (115)
Connecticut (117)
Europe (79193)
Florida (385)
Georgia (98)
Illinois (306)
Indiana (175)
Kansas (95)
Maryland (507)
Massachusetts (2165)
Michigan (142)
Minnesota (246)
New Jersey (805)
New York (824)
North Carolina (656)
Northern California (1177)
Ohio (123)
Pennsylvania (737)
South America (1091)
Southern California (1062)
Texas (372)
Utah (77)
Washington State (315)
682,992 Results for "veracyte inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veracyte to Participate in Upcoming Investor Conferences
October 30, 2024
·
1 min read
Biotech Bay
Veracyte to Participate in Upcoming Investor Conferences - May 15, 2024
Veracyte, Inc. a leading cancer diagnostics company, announced it will participate in the following investor conferences.
May 15, 2024
·
1 min read
Business
Veracyte Announces First Quarter 2024 Financial Results
Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
17 min read
Biotech Bay
Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive disease.
June 3, 2024
·
8 min read
Business
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024.
April 22, 2024
·
1 min read
Press Releases
Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024
October 17, 2024
·
1 min read
Press Releases
New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men
October 2, 2024
·
6 min read
Biotech Bay
New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate cancer, the Decipher Prostate Genomic Classifier is prognostic for identifying those whose disease is likely to progress.
April 22, 2024
·
6 min read
Press Releases
New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer
September 16, 2024
·
7 min read
Biotech Bay
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer.
May 22, 2024
·
5 min read
1 of 68,300
Next
